Full-length publication on the overall survival of “real-life” patients versus patients in clinical trials

Veröffentlicht am January 2, 2017 in News

“Real-life” patients, such as the patients in the tumour registry of advanced renal cell carcinoma, often do not fulfil the strict inclusion criteria in clinical trials and are therefore considered “trial inappropriate”. An analysis in the tumour registry of renal cell carcinoma showed that this applies to almost 60% of all mRCC patients in clinical routine practice in Germany. Compared to patients from clinical trials the overall survival of “trial inappropriate” patients is clearly lower. The data analysis was recently published in Clinical Genitourinary Cancer.

iOMEDICO AG
Hanferstraße 28
D-79108 Freiburg

Phone: 0761 - 15 242 0
E-Mail: info@iomedico.com